THE QUALITY AND EQUIVALENCE OF TOPICAL
PRODUCTS AND CHALLENGES Of NANOTECHNOLOGY
Specialized in the field of preclinical studies Labhnn is organizing its first hybrid workshop with the contribution of four international experts
See you in Geneva on April 06 2021
EMA’s proposed guideline on quality and equivalence of topical products - future advances and challenges
On 6 April 2021
PROF. Christian Surber
Christian Surber, Ph.D., is Professor of Dermatopharmacology and Hospital Pharmacy at the University of Basel and visiting Professor at the Departments of Dermatology
Looking for targeted customer ?
Dr. Nathalie Hasler-Nguyen, a biologist by training with a PhD in Pharmacology and Biochemistry, has managed a preclinical laboratory for the past 20 years. In addition, she has collaborated with many outside partners in the development of topical products for the pharmaceutical industry.
If you have any question about the event, please contact us at firstname.lastname@example.org
Photographer & Video Editing
Marketing & Logistics
For your venue we propose to book a room at Hotel Le Cenacle at 17, promenade Charles-Martin, 1208 Geneva .
Stay up to date
I’m Stefan Mühlebach, Prof. em. in Pharmacology and Hospital Pharmacy at the University of Basel in Switzerland. Due to my activity in nanopharmaceutical and regulatory science, I was a founding member of the Non-Biological Complex Drugs working party in the Netherland more the 10 years ago.
My name is Richard Guy. I am Professor of Pharmaceutical Science at the University of Bath in the UK. Since 2013, my research has been funded by the FDA’s Office of Generic Drugs to develop and validate methods to assess the bioequivalence of topical drug products.
Dr. Vinod Shah, one of the hybrid workshop speakers about the Quality and Equivalence of Topical Products and Nanotechnology Challenges, is introducing his talk. This event will be held on 6 April 2021 in Geneva.